CMS expands MRI coverage for patients with heart devices

MRIdian treatment planning
The Medicare agency has moved to expand coverage of MRIs to patients with an implanted cardiac device, without "evidence-based" restrictions. (ViewRay)

The Centers for Medicare & Medicaid Service (CMS) is making it easier for patients with certain implantable devices to get MRI scans. 

As part of a coverage decision, the federal agency is expanding MRI coverage for patients with an implanted cardiac device, without the need for "evidence development."

Medicare coverage for MRI services for such patients started in 2011, but only if the patients were part of a clinical trial, due to safety concerns. 

Conference

2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

"We determined that the evidence is sufficient to conclude that [MRIs] for Medicare beneficiaries with an implanted pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy pacemaker, or cardiac resynchronization therapy defibrillator is reasonable and necessary for the diagnosis or treatment of illness or injury," the agency said.

The memo, however, did not specify an effective date for the finalized changes. The decision follows research released earlier this year by the New England Journal of Medicine that found MRIs safe for patients with cardiac devices. 

RELATED: Anthem alters controversial ER coverage policies

During the proposal stage, CMS considered not extending the coverage to patients who were pacemaker dependent and a six-week wait period after device insertion for any surgical modification. Both proposals were later dropped. 

MRIs are expensive, and private insurers have made attempts at moving patients away from the services in hospital settings—and caught flak for it. Last year, Anthem attempted to curb costs by steering patients towards freestanding imaging centers. After backlash from providers, the insurer walked back some parts of the new policy in February. 

Suggested Articles

Health insurers’ financial performance is on a continuing upward trend, but political and legal risks could pose a threat to that growth.

Senate lawmakers released a draft package of legislation aimed at curbing healthcare costs they said they believe they can pass on a bipartisan basis.

Attorneys general seeking to defend the ACA argue that their opponents—including the DOJ—have poor legal standing to challenge the law.